AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (April 8, 2008). doi:10.1152/ajpendo.90245.2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Douard, V.
Right arrow Articles by Ferraris, R. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douard, V.
Right arrow Articles by Ferraris, R. P.
Submitted on February 20, 2008
Revised on March 25, 2008
Accepted on March 27, 2008

Regulation of the fructose transporter GLUT5 in health and disease

Veronique Douard and Ronaldo P. Ferraris1*

1 UMDNJ-New Jersey Medical School

* To whom correspondence should be addressed. E-mail: ferraris{at}umdnj.edu.

Fructose is now such an important component of human diets that increasing attention is being focused on the fructose transporter GLUT5. In this review, we describe the regulation of GLUT5 not only in the intestine and testis where it was first discovered but also in the kidney, skeletal muscle, fat tissue and brain where increasing numbers of cell types have been found to have GLUT5. GLUT5 expression levels and fructose uptake rates are also significantly affected by diabetes, hypertension, obesity and inflammation, and seem to be induced during carcinogenesis, particularly in the mammary glands. We end by highlighting research areas that should yield information needed to better understand the role of GLUT5 during normal development, metabolic disturbances, and cancer.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.